Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Using <i>sno- lncRNAs</i> as potential markers for Prader-Willi syndrome diagnosis

Molecular genetic diagnostics of Prader-Willi Syndrome: a validation of linkage analysis for the Chinese population.

Prader-willi syndrome:a clinical and epigenetic study of 4 cases

A Preliminary Study of Molecular Diagnostics in Prader-Willi Syndrome

Prader- Willi Syndrome and Genomic Imprinting

Clinical and genetic analysis for four Chinese families with Prader–Willi syndrome

Unusual Processing Generates SPA LncRNAs that Sequester Multiple RNA Binding Proteins.

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Clinical and epigenetic study of a case of Prader-Willi syndrome

Lack of Pwcr1/MBII-85 Snorna is Critical for Neonatal Lethality in Prader–Willi Syndrome Mouse Models

Diagnosis of Prader-Willi syndrome and Angelman syndrome by targeted nanopore long-read sequencing

Diagnosis of Prader-Willi Syndrome with Methylation Test

Translocation Breakpoint Disrupting the Host SNHG14 Gene but Not Coding Genes or Snornas in Typical Prader-Willi Syndrome

Loss of Heterozygosity on the Distal Long Arm of Chromosome 15: an Allusion for Prader-willi Syndromes?

Rapid Diagnosis of Imprinting Disorders Involving Copy Number Variation and Uniparental Disomy Using Genome-Wide SNP Microarrays

Methylation-specific Multiplex Ligation-Dependent Probe Amplification in Diagnosis of Prader-Willi Syndrome and Angelman Syndrome

Concordance of whole-genome long-read sequencing with standard clinical testing for Prader-Willi and Angelman syndromes

A rapid and accurate methylation‐sensitive high‐resolution melting analysis assay for the diagnosis of Prader Willi and Angelman patients

Genetic testing for Prader-Willi syndrome and Angelman syndrome in the clinical practice of Guangdong Province, China

Microarray Expression Profiling of Dysregulated Long Non-Coding Rnas in Hirschsprung'S Disease Reveals Their Potential Role in Molecular Diagnosis

Clinical and Genetic Features of Prader-Willi Syndrome in China